These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1786081

  • 21. Microbial toxins and Kawasaki disease.
    Glode MP, Brogden RL, Joffe LS, Wiggins JW.
    Prog Clin Biol Res; 1987; 250():81-6. PubMed ID: 3423084
    [No Abstract] [Full Text] [Related]

  • 22. Detection of multiple superantigen genes in stools of patients with Kawasaki disease.
    Suenaga T, Suzuki H, Shibuta S, Takeuchi T, Yoshikawa N.
    J Pediatr; 2009 Aug; 155(2):266-70. PubMed ID: 19446844
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clonal expansion of CD8+ T cells in Kawasaki disease.
    Choi IH, Chwae YJ, Shim WS, Kim DS, Kwon DH, Kim JD, Kim SJ.
    J Immunol; 1997 Jul 01; 159(1):481-6. PubMed ID: 9200489
    [Abstract] [Full Text] [Related]

  • 26. Superantigens and streptococcal toxic shock syndrome.
    Proft T, Sriskandan S, Yang L, Fraser JD.
    Emerg Infect Dis; 2003 Oct 01; 9(10):1211-8. PubMed ID: 14609454
    [Abstract] [Full Text] [Related]

  • 27. Kawasaki disease: relationship between acute surgical abdomen and cytokine profiles.
    Miyamoto K, Yamazaki Y, Okamoto K, Tsuboi T, Hirao J, Arisaka O.
    Pediatr Infect Dis J; 2013 Nov 01; 32(11):1299. PubMed ID: 24141803
    [No Abstract] [Full Text] [Related]

  • 28. Recurrent mucocutaneous lymph node syndrome (Kawasaki disease): a report of three cases.
    Keren G, Passwell J, Cohen BE.
    J Med; 1986 Nov 01; 17(5-6):365-71. PubMed ID: 3473170
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Biochemical and immunological laboratory findings in Kawasaki disease].
    Ogawa S.
    Nihon Rinsho; 2008 Feb 01; 66(2):315-20. PubMed ID: 18260330
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Recurrent toxin-mediated perineal erythema.
    Manders SM, Heymann WR, Atillasoy E, Kleeman J, Schlievert PM.
    Arch Dermatol; 1996 Jan 01; 132(1):57-60. PubMed ID: 8546484
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Serum interferon concentrations and retroviral serology in Kawasaki syndrome.
    Rowley AH, Shulman ST, Preble OT, Poiesz BJ, Ehrlich GD, Sullivan JR.
    Pediatr Infect Dis J; 1988 Sep 01; 7(9):663-6. PubMed ID: 3140211
    [No Abstract] [Full Text] [Related]

  • 35. Superantigens and their role in infectious disease.
    Schafer R, Sheil JM.
    Adv Pediatr Infect Dis; 1995 Sep 01; 10():369-90. PubMed ID: 7718212
    [Abstract] [Full Text] [Related]

  • 36. [Kawasaki disease].
    Lebranchu Y.
    Ann Dermatol Venereol; 1993 Sep 01; 120(9):587-8. PubMed ID: 8161111
    [No Abstract] [Full Text] [Related]

  • 37. HLA antigens in mucocutaneous lymph node syndrome in New England.
    Krensky AM, Berenberg W, Shanley K, Yunis EJ.
    Pediatrics; 1981 May 01; 67(5):741-3. PubMed ID: 7255009
    [Abstract] [Full Text] [Related]

  • 38. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
    Rowley AH, Shulman ST.
    Pediatr Res; 1998 Feb 01; 43(2):291-3. PubMed ID: 9475299
    [No Abstract] [Full Text] [Related]

  • 39. Evidence for superantigen mediated process in Kawasaki disease.
    De Inocencio J, Hirsch R.
    Arch Dis Child; 1995 Sep 01; 73(3):275-6. PubMed ID: 7492179
    [No Abstract] [Full Text] [Related]

  • 40. Immunological abnormalities in Kawasaki disease.
    Okumura K, Jujho K, Yanase Y.
    Prog Clin Biol Res; 1987 Sep 01; 250():167-74. PubMed ID: 3423036
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.